UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 1,032 | -5.7% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 1,094 | -10.4% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 1,221 | +19.7% | 0.00% | – |
Q4 2021 | $1,000 | -50.0% | 1,020 | +25.9% | 0.00% | – |
Q3 2021 | $2,000 | -50.0% | 810 | 0.0% | 0.00% | – |
Q2 2021 | $4,000 | -93.3% | 810 | -91.8% | 0.00% | – |
Q1 2021 | $60,000 | -82.5% | 9,904 | -84.9% | 0.00% | – |
Q4 2020 | $343,000 | +383.1% | 65,419 | +216.4% | 0.00% | – |
Q3 2020 | $71,000 | -94.2% | 20,676 | -85.3% | 0.00% | – |
Q2 2020 | $1,220,000 | +883.9% | 140,595 | +558.5% | 0.00% | – |
Q1 2020 | $124,000 | +4.2% | 21,352 | +28.9% | 0.00% | – |
Q4 2019 | $119,000 | +17.8% | 16,571 | +0.4% | 0.00% | – |
Q3 2019 | $101,000 | -31.3% | 16,500 | +7.2% | 0.00% | – |
Q2 2019 | $147,000 | +24.6% | 15,396 | +6.6% | 0.00% | – |
Q1 2019 | $118,000 | -78.0% | 14,445 | -56.2% | 0.00% | – |
Q4 2018 | $536,000 | +1310.5% | 32,947 | +1309.8% | 0.00% | – |
Q3 2018 | $38,000 | +216.7% | 2,337 | +185.7% | 0.00% | – |
Q2 2018 | $12,000 | – | 818 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
Caption Management, LLC | 725,000 | $409,000 | 0.01% |
Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
Caption Management, LLC | 225,000 | $127,000 | 0.00% |
SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |